ESMO 2014: The TRACERx study of lung cancer

At ESMO 2014 Congress, Prof Charles Swanton (London Research Institute and UCL, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which is a study that defines lung cancer in both space and time through multiregion and longitudinal tumour sampling and genetic analysis.

Year of Production:
Running Time:
Color/Sound:

2015
01:34
Color/Sound

Keywords:

Comments are closed.